Published in Medical Devices and Surgical Technology Week, October 16th, 2005
Ophthalmologists in Israel conducted a study "to evaluate the clinical outcome of wavefront-guided laser in situ keratomileusis (LASIK) for the treatment of moderate to high myopia associated with a thin cornea."
"This retrospective study included 98 eyes of 49 patients with moderate to high myopia (-5.20 to -10.35 diopters [D]) and thin corneas (456 to 498 microm) treated with wavefront-guided LASIK (Zyoptix, Bausch & Lomb) and followed for 36 months," explained I. Kremer and coauthors at the Rabin Medical Center. "Preoperative wavefront analysis was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.